Open access
Jul 2026
Pneumococcal infection in the elderly: cost-effectiveness of vaccination to reduce demographic losses
Vaccination of Russian people aged ≥60 years with PCV20 provides the greatest reduction in pneumococcal infection incidence and is highly cost-effective compared to PPV23 vaccination and is cost-effective compared to sequential PCV13/PPV23 vaccination.
A. V. Rudakova, S. Avdeev, L. Namazova-Baranova et al.
· CARDIOVASCULAR THERAPY AND P... · 0 citations